Home Overview Press Room Blog Publications For Students about us

Genetic Selection : Displaying 11-20 of 481

Would you edit your unborn child’s genes so they were successful?by Mairi LevittThe GuardianNovember 3rd, 2015A parent’s desire to do the best for their child could create problems.
Genetic testing evolves, along with health and ethics debatesby Michael HiltzikLos Angeles TimesOctober 30th, 2015The FDA approved 23andMe to provide carrier tests, turning the personal genomics service into a direct-to-consumer family-planning tool, but without the genetic counselor to explain carrier status risks.
Would you take a genetic test that could lay bare your destiny?by Rowan HooperNew ScientistOctober 29th, 2015Plaques and Tangles, a play now at the Royal Court in London, takes on issues of personal genomics, carrier status testing, and Alzheimer's, asking: "Are we architects of our own destiny or prisoners of our genes?"
Genetic Surveillance: Consumer Genomics and DNA Forensicsby Elliot Hosman, Biopolitical TimesOctober 29th, 2015As more biotech companies move to “cash in on the genome,” we need to connect the conversations on personal genomics, DNA forensics, immigration, and biological discrimination.
Human Gene Editing Frequently Asked QuestionsOctober 29th, 2015Should we as a society condone the genetic modification of future human beings? Here we take on some common questions about gene editing the human germline.
NAS Human Gene Editing Meeting: Agenda & Public Participationby Paul KnoepflerThe NicheOctober 26th, 2015The National Academies have released a draft agenda for the upcoming summit on human gene editing.
Making Indigenous Peoples Equal Partners in Gene Researchby Ed YongThe AtlanticOctober 23rd, 2015After leaving a partnership with NIH in 2003, the Akimel O’odham (Pima) tribe is retaining control of their bio samples and shaping the goals of a diabetes project with genomic researchers.
Cops Want To Look At 23andMe Customers’ DNAby Stephanie M. LeeBuzzFeedOctober 21st, 2015The FBI and other agencies have asked for — and been denied — five users’ data, according to a new transparency report on the company's website, and chain of custody could be a legal obstacle for future requests.
23andMe Will Resume Giving Users Health Databy Andrew PollackThe New York TimesOctober 21st, 2015Two years after a forced hiatus from providing consumers with genetic health probabilities, the FDA has cleared 23andMe to provide carrier status and lactose intolerance tests.
What's Your DNA Worth? The Scramble to Cash In On The Genome[cites CGS's Marcy Darnovsky]by Alex LashXconomyOctober 20th, 2015Vast pools of genomic data may unlock health secrets, but what is the risk of "sharing" our data for biotech corporate profits, and is it greater than the nebulous future rewards?
Displaying 11-20 of 481  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760